Date(s) And Time(s):
Sep 13 2010 8:00AM - Sep 14 2010 5:00PM
SAS Radisson Hotel Boulogne
Av. Edouard Vaillant 33
92660 Boulogne-Billancourt (Paris)
Clinical Safety/Pharmacovigilance, Clinical Research, Nonclinical
The 17th edition of this annual training course, considered by many experts as one of the pillars of medical training in pharmacovigilance, focuses on how to use the medical knowledge in the diagnosis and management of selected Adverse Drug Reactions (ADRs).
A medical approach is needed for the identification, labelling and understanding of ADR mechanisms. It can also improve the evaluation of the probability that a medicinal product may have played a role in the occurrence of an adverse event. This is particularly useful for the first 2 or 3 cases of serious reactions occurring during clinical trials when important decisions must be taken regarding a new drug under development.
The medical approach presented during this training course is mainly based on the conclusions of international or national consensus
meetings on adverse drug reactions.
Medical Approach in Clinical Safety
Drug-Associated Affective Symptoms
Drug-Induced Blood Disorders
Drug-Induced Liver Disorders
Drugs in Pregnancy
Drug-Induced Renal Disorders
Drug-Induced Skin Reactions
Drug-Induced QT Prolongation
At the conclusion of this seminar participants should be able to:
Classify and define drug induced disorders for each system organ
Describe their clinical pattern and different etiological investigations
Discuss specifically drug-induced liver injury during clinical trials and in postmarketing.
All healthcare professionals involved in the monitoring and assessment of adverse drug reactions occurring during development or after marketing; people in charge of pharmacovigilance, investigators, clinical research associates and monitors.
TEL.: +41 61 225 51 51
FAX: +41 61 225 51 52